New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Merck & Co., Inc.

MRK

Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.

Revenue
+4.68%
EPS
−12.1%
Free cash flow
−19.3%
Total debt
+24.3%

Quarter to September 2026, against a year earlier

134.93 2.19 +1.65%
Market cap
$328.6B
P/E
137×
Fwd P/E FY26e
105×
Dividend yield
2.56%
F-score
4/9
ROIC
4.56%
Net debt / EBITDA
1.2×
Payout ratio
3.5×

What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025

It owes $32.2B more in debt than it holds in cash and short-term investments. Debt has risen from $24.3B to $46.8B since FY16. Shareholders’ equity is 38.5% of the balance sheet. What is a balance sheet?

Dec 31, 2025 · total $136.9B

Owns

$93.4BLong-term assets
$29.0BOther short-term assets
$14.6BCash & short-term investments

Funded by

$52.7BShareholders’ equity
$37.5BOther liabilities
$46.8BDebt

Debt is 34.2% of the total; shareholders’ equity 38.5%.

Net debt rose from 10% of assets to 24% since FY16.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, ten years
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Total assets$95.4B$87.9B$82.6B$84.4B$91.6B$105.7B$109.2B$106.7B$117.1B$136.9B
Net debt (debt less cash)$9.9B$12.9B$10.9B$12.3B$17.3B$22.6B$15.6B$26.6B$20.8B$32.2B
Net debt ÷ assets (right axis)10.4%14.6%13.2%14.6%18.9%21.4%14.2%24.9%17.7%23.5%
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
43,516.00 38,782.00 32,168.00 35,722.00 30,266.00 27,764.00 27,483.00 25,875.00 24,766.00 30,614.00
Total non-current assets
93,350.00 78,324.00 74,507.00 73,438.00 75,428.00 63,824.00 56,914.00 56,762.00 63,106.00 64,763.00
Total Assets
136,866.00 117,106.00 106,675.00 109,160.00 105,694.00 91,588.00 84,397.00 82,637.00 87,872.00 95,377.00
Total current liabilities
28,327.00 28,420.00 25,694.00 24,239.00 23,872.00 27,327.00 22,220.00 22,206.00 18,614.00 17,204.00
Total non-current liabilities
55,877.00 42,314.00 43,346.00 38,863.00 43,565.00 38,857.00 36,176.00 33,549.00 34,689.00 37,865.00
Total liabilities
84,204.00 70,734.00 69,040.00 63,102.00 67,437.00 66,184.00 58,396.00 55,755.00 53,303.00 55,069.00
Common Equity (Total)
52,662.00 46,372.00 37,635.00 46,058.00 38,257.00 25,404.00 26,001.00 26,882.00 34,569.00 40,308.00
Shareholders Equity (Total)
52,662.00 46,372.00 37,635.00 46,058.00 38,257.00 25,404.00 26,001.00 26,882.00 34,569.00 40,308.00
Total Debt
46,750.00 34,462.00 33,683.00 28,745.00 30,690.00 25,360.00 22,736.00 19,806.00 21,353.00 24,274.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026